Ranked by engagement
Top topics — this year page 8
Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,076 topics · page 8 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A supplier who responds to a discrepancy with silence — what changed since
A supplier who responds to a discrepancy with silence — what changed since — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+83 | 88 | 21k | 6h |
|
What a purity-only report leaves out
What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+92 | 105 | 4k | 8mo |
|
Second pass at: Sleep apnoea improving and the equipment implications
On the subject in the title: Second pass at: Sleep apnoea improving and the equipment implications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
|
+89 | 96 | 1.1k | 10h |
|
Power cut for eleven hours: how I assessed it afterwards
Posting this under the heading it deserves: Power cut for eleven hours: how I assessed it afterwards Everything below is what sits behind that. Practical question with the units stated, because I have seen…
|
+102 | 109 | 1.4k | 9mo |
|
A parcel stationary at a customs facility for nine days
On the subject in the title: A parcel stationary at a customs facility for nine days Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else…
|
+64 | 72 | 51k | 1mo |
|
Citation sweep results: how many references did not say what was claimed
On the subject in the title: Citation sweep results: how many references did not say what was claimed Working notes rather than a conclusion. Process question about how this site works. I have read the…
|
+92 | 101 | 2.9k | 2mo |
|
Stability of BPC-157 in solution: what has been measured — one year on
On the subject in the title: Stability of BPC-157 in solution: what has been measured — one year on Working notes rather than a conclusion. Comparing STEP 2 ( Lancet , 2021) with STEP 1 ( N Engl J Med , 2021)…
|
+84 | 98 | 7.8k | 18h |
|
Follow-up: Prior authorisation: what the criteria usually require
Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
|
+95 | 100 | 9.1k | 10h |
|
Follow-up: History of disordered eating and why it changes the conversation
Posting this under the heading it deserves: History of disordered eating and why it changes the conversation Everything below is what sits behind that. General question, not a request for advice about my own…
|
+75 | 81 | 23k | 10mo |
|
Prescription requirements and telehealth models
Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+91 | 97 | 5.4k | 7mo |
|
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question
Posting this under the heading it deserves: Journal club: orforglipron phase 2 and the non-peptide question Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
|
+80 | 91 | 10k | 11mo |
|
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+90 | 96 | 4.1k | 4mo |
|
Triple agonism: additive, synergistic, or neither?
The question in the title: Triple agonism: additive, synergistic, or neither? I will give what I have already checked below so nobody repeats it. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
|
+71 | 80 | 38k | 11mo |
|
Dead volume across syringe and needle combinations
On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go wrong…
|
+72 | 80 | 28k | 5mo |
|
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
|
+97 | 104 | 15k | 3mo |
|
Muscle cramps: the ordinary causes before the exotic ones — a second dataset
Posting this under the heading it deserves: Muscle cramps: the ordinary causes before the exotic ones — a second dataset Everything below is what sits behind that. Reporting something rather than asking about…
|
+65 | 77 | 39k | 1d |
|
Reconstitution volumes that produce round numbers, tabulated
Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly…
|
+103 | 112 | 1.7k | 3mo |
|
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in…
|
+107 | 111 | 12k | 1d |
|
Payment mechanics and the recovery options that do not exist
Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
|
+80 | 89 | 24k | 9mo |
|
Why retatrutide discussion here is more cautious than elsewhere — one year on
Asking directly, because I could not find a straight answer: Why retatrutide discussion here is more cautious than elsewhere — one year on Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it…
|
+92 | 97 | 3.6k | 20h |
|
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem
On the subject in the title: Lateral-flow and colorimetric approaches: the specificity problem Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+77 | 89 | 16k | 9h |
|
The most useful thing you learned here that was not the answer you came for
The most useful thing you learned here that was not the answer you came for Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still…
|
+54 | 61 | 57k | 1d |
|
[2026 update] Does dual agonism explain the effect size, or is it dose?
Asking directly, because I could not find a straight answer: Does dual agonism explain the effect size, or is it dose? Session topic: SELECT ( N Engl J Med , 2023). Please read it before posting; the…
|
+58 | 63 | 40k | 9mo |
|
[2026 update] A rising related-substance total over six months: degradation or method drift?
The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody repeats it. Posting the method first, because…
|
+71 | 78 | 34k | 5mo |
|
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes
The SOUL trial and oral semaglutide cardiovascular outcomes — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+100 | 104 | 4.2k | 5mo |
|
Endotoxin and why it is a separate question from purity — what changed since
On the subject in the title: Endotoxin and why it is a separate question from purity — what changed since Working notes rather than a conclusion. A documentation question rather than an analytical one. I have…
|
+78 | 91 | 1k | 10h |
|
Second pass at: How to ask a question when you cannot say why you are asking it
Second pass at: How to ask a question when you cannot say why you are asking it — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to…
|
+73 | 81 | 16k | 4mo |
|
Revisiting: Protein density versus volume when you cannot eat much
Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+97 | 108 | 3.6k | 2d |
|
Measurement error in home scales, with a worked standard deviation — the long version
On the subject in the title: Measurement error in home scales, with a worked standard deviation — the long version Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022).…
|
+96 | 105 | 2k | 2mo |
|
How to ask about something you suspect is a bad idea
The question in the title: How to ask about something you suspect is a bad idea I will give what I have already checked below so nobody repeats it. Question in the title. Context below, and I have tried to…
|
+81 | 87 | 16k | 2mo |